Neuromuscular Junction Development and Disorders

The neuromuscular junction (NMJ) constitutes a specialised synapse between a motor neuron and a skeletal muscle fibre, orchestrating voluntary movement via rapid conversion of electrical impulses into muscle contraction. Its development involves a sequence of events beginning with prepatterning of the muscle membrane, the secretion of Agrin by growing motor axons, the activation of the Lrp4–MuSK complex, and the subsequent recruitment and clustering of acetylcholine receptors (AChRs) by rapsyn. Precise trans-synaptic alignment with presynaptic active zones and a stable extracellular matrix are essential for synaptic efficacy and maintenance. Disruption of any component in this finely tuned system gives rise to a broad spectrum of disorders: congenital myasthenic syndromes (CMS) result from inherited mutations affecting pre-, synaptic or postsynaptic proteins; autoimmune myasthenia gravis arises from pathogenic antibodies to AChRs or MuSK; Lambert–Eaton myasthenic syndrome stems from presynaptic calcium channel autoimmunity; and age-related sarcopenia reflects degenerative changes in NMJ integrity and extracellular matrix composition. Advances in molecular biology, structural analysis and network-based approaches are converging to deepen our understanding of NMJ assembly, homeostasis and pathology, offering new avenues for targeted therapies and precision medicine.

Research from Nature Portfolio

A multilayer network analysis has been applied to elucidate the molecular determinants of severity in congenital myasthenic syndromes. By integrating patient-specific genetic variants with protein–protein interactions, signalling pathways and metabolomic profiles, this approach identified extracellular matrix components and postsynaptic regulators of AChR clustering as key modulators of clinical phenotype. The workflow enables personalised mapping of disease mechanisms, revealing how distinct alterations in synaptic architecture and receptor aggregation correlate with variable disease severity and pointing to novel molecular targets for tailored interventions in rare NMJ disorders.

Neuromuscular Junction Development and Disorders publication trend

The graph below shows the total number of articles in neuromuscular junction development and disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Neuromuscular junction (NMJ): A specialised synapse between a motor neuron and a muscle fibre that mediates muscle contraction through neurotransmitter release and receptor activation.

Acetylcholine receptor (AChR): A ligand-gated ion channel on the muscle membrane that mediates endplate potentials in response to acetylcholine.

Congenital myasthenic syndromes (CMS): Inherited disorders of NMJ transmission caused by mutations in proteins at the pre-, synaptic or postsynaptic compartments.

Agrin: A nerve-derived extracellular matrix protein that organises postsynaptic differentiation and AChR clustering via Lrp4-MuSK signalling.

Multilayer network analysis: An integrative computational approach combining genetic, proteomic and metabolomic data to map disease-associated molecular interactions.

Choline transporter (CHT1): A sodium- and chloride-coupled transporter responsible for choline uptake in cholinergic neurons, essential for acetylcholine synthesis.

References

1. The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis. Frontiers in Molecular Neuroscience (2020).
2. Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes. Nature Communications (2024).
3. Structural mechanisms of human sodium-coupled high-affinity choline transporter CHT1. Cell Discovery (2024).
4. Deficiency of skeletal muscle Agrin contributes to the pathogenesis of age-related sarcopenia in mice. Cell Death & Disease (2024).
5. Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes—A Comprehensive Review. International Journal of Molecular Sciences (2023).